Harmony Biosciences: BlackRock reports 12.6% stake

BlackRock reported sole voting authority over 7,269,051 shares and sole dispositive authority over 7,361,888 shares.

Rhea-AI Filing Summary

Harmony Biosciences Holdings, Inc. (HRMY) reported that BlackRock, Inc. beneficially owned 7,361,888 common shares, or 12.6%, as of September 30, 2026. BlackRock reported sole voting power over 7,269,051 shares and sole dispositive power over 7,361,888 shares, with no shared voting or dispositive power. It identified iShares Core S&P Small-Cap ETF as having an interest in more than 5% of the company's outstanding common stock.

Key Figures

Beneficially owned: 7,361,888 shares Percent of class: 12.6% Sole voting power: 7,269,051 shares +3 more

6 metrics

Beneficially owned 7,361,888 shares As of September 30, 2026

Percent of class 12.6% As of September 30, 2026

Sole voting power 7,269,051 shares As of September 30, 2026

Sole dispositive power 7,361,888 shares As of September 30, 2026

Shared voting power 0 shares As of September 30, 2026

Shared dispositive power 0 shares As of September 30, 2026

Key Terms

Amount beneficially owned, Sole power to vote or to direct the vote, Sole power to dispose or to direct the disposition

3 terms

Amount beneficially owned regulatory

"Amount beneficially owned: 7361888"

Sole power to vote or to direct the vote regulatory

"Sole power to vote or to direct the vote: 7269051"

Sole power to dispose or to direct the disposition regulatory

"Sole power to dispose or to direct the disposition of: 7361888"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many HRMY shares does BlackRock beneficially own?

BlackRock, Inc. reported beneficial ownership of 7,361,888 Harmony Biosciences common shares, or 12.6% of the class, as of September 30, 2026. It reported sole voting power over 7,269,051 shares.

Which holder had an interest in more than 5% of HRMY?

iShares Core S&P Small-Cap ETF was identified as having an interest in Harmony Biosciences common stock representing more than 5% of the total outstanding common stock.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 10/27/2026 - 05:28 PM EDT Accepted by SEC EDGAR 10/27/2026 - 05:25 PM EDT Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 7)

Harmony Biosciences Holdings, Inc.

(Name of Issuer)

Common Stock

(Title of Class of Securities)

413197104

(CUSIP Number)

09/30/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 413197104

1

Names of Reporting Persons

BlackRock, Inc.

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 7,269,051.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 7,361,888.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

7,361,888.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

12.6 %

12

Type of Reporting Person (See Instructions)

HC

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Harmony Biosciences Holdings, Inc.
(b)	Address of issuer's principal executive offices: 630 W GERMANTOWN PIKE, SUITE 215 PLYMOUTH MEETING PA 19462
Item 2.
(a)	Name of person filing: BlackRock, Inc. In accordance with SEC Release No. 34-39538 (January 12, 1998), this Schedule 13G reflects the securities beneficially owned, or deemed to be beneficially owned, by certain business units (collectively, the "Reporting Business Units") of BlackRock, Inc. and its subsidiaries and affiliates. It does not include securities, if any, beneficially owned by other business units whose beneficial ownership of securities are disaggregated from that of the Reporting Business Units in accordance with such release.
(b)	Address or principal business office or, if none, residence: BlackRock, Inc., 50 Hudson Yards New York, NY 10001
(c)	Citizenship: See Item 4 of Cover Page
(d)	Title of class of securities: Common Stock
(e)	CUSIP No.: 413197104
Item 4.	Ownership
(a)	Amount beneficially owned: 7361888
(b)	Percent of class: 12.6 %
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 7269051
	(ii) Shared power to vote or to direct the vote: 0
	(iii) Sole power to dispose or to direct the disposition of: 7361888
	(iv) Shared power to dispose or to direct the disposition of: 0
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required. The interest of 1 such person, iShares Core S&P Small-Cap ETF, in the common stock of Harmony Biosciences Holdings, Inc. is more than five percent of the total outstanding common stock.
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	If a parent holding company has filed this schedule, pursuant to Rule 13d-1(b)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary. If a parent holding company has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary. See Exhibit 99
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

BlackRock, Inc.

Signature:	Spencer Fleming
Name/Title:	Managing Director
Date:	10/27/2026

Exhibit Information

Exhibit 24: Power of Attorney Exhibit 99: Item 7